1. Home
  2. TROX vs NBTX Comparison

TROX vs NBTX Comparison

Compare TROX & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$6.50

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$34.55

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
NBTX
Founded
2018
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
TROX
NBTX
Price
$6.50
$34.55
Analyst Decision
Hold
Strong Buy
Analyst Count
8
1
Target Price
$6.07
$26.00
AVG Volume (30 Days)
4.3M
38.2K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
3.06%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,898,000,000.00
N/A
Revenue This Year
$6.49
N/A
Revenue Next Year
$4.86
$11.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$2.95
52 Week High
$8.80
$37.11

Technical Indicators

Market Signals
Indicator
TROX
NBTX
Relative Strength Index (RSI) 44.07 68.93
Support Level $4.98 $20.11
Resistance Level $6.96 N/A
Average True Range (ATR) 0.62 2.03
MACD -0.14 0.81
Stochastic Oscillator 6.78 76.70

Price Performance

Historical Comparison
TROX
NBTX

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: